MIRA INFORM REPORT

 

 

Report Date :

24.12.2013

 

IDENTIFICATION DETAILS

 

Name :

PINEWOOD LABORATORIES LIMITED

 

 

Registered Office :

Ballymacarbry Clonmel Co Tipperary 169221

 

 

Country :

Ireland

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

26.08.1976

 

 

Com. Reg. No.:

IE056296

 

 

Legal Form :

Not Available

 

 

Line of Business :

Manufacture of basic pharmaceutical products

 

 

No. of Employees :

339

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Ireland

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

ireland - ECONOMIC OVERVIEW

 

Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity has dropped sharply since the onset of the world financial crisis, with GDP falling by over 3% in 2008, nearly 7% in 2009, and less than 1% in 2010. Ireland entered into a recession in 2008 for the first time in more than a decade, with the subsequent collapse of its domestic property and construction markets. Property prices rose more rapidly in Ireland in the decade up to 2007 than in any other developed economy. Since their 2007 peak, average house prices have fallen 47%. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become a key component of Ireland's economy. Agriculture, once the most important sector, is now dwarfed by industry and services. In 2008 the former COWEN government moved to guarantee all bank deposits, recapitalize the banking system, and establish partly-public venture capital funds in response to the country's economic downturn. In 2009, in continued efforts to stabilize the banking sector, the Irish Government established the National Asset Management Agency (NAMA) to acquire problem commercial property and development loans from Irish banks. Faced with sharply reduced revenues and a burgeoning budget deficit, the Irish Government introduced the first in a series of draconian budgets in 2009. In addition to across-the-board cuts in spending, the 2009 budget included wage reductions for all public servants. These measures were not sufficient. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP - because of additional government support for the banking sector. In late 2010, the former COWEN government agreed to a $112 billion loan package from the EU and IMF to help Dublin further increase the capitalization of its banking sector and avoid defaulting on its sovereign debt. Since entering office in March 2011, the new KENNY government has intensified austerity measures to try to meet the deficit targets under Ireland's EU-IMF program. Ireland achieved moderate growth of 1.4% in 2011 and cut the budget deficit to 9.1% of GDP. Although the recovery slowed in 2012 because of weaker EU demand for Irish exports, Dublin managed to trim the deficit to about 8.5% of GDP.

 

Source : CIA

 


Company identification

 

Company Name:

PINEWOOD LABORATORIES LIMITED

Company No:

IE056296

Registered Address:

BALLYMACARBRY

CLONMEL

CO TIPPERARY

169221

 

              

Company Name

PINEWOOD LABORATORIES LIMITED

Company Number

IE056296

Registered Address

BALLYMACARBRY
CLONMEL
CO TIPPERARY
169221

 



Website Address

-

 

 

Telephone Number

05236253

 

 

TPS

No

 

 

Incorporation Date

26/08/1976

Company Status

Active - Accounts Filed

Previous Name

 

Type

Other

Date of Change

-

Filing Date of Accounts

-

 

 

Share Capital

€373,291

SIC03

24410

Currency

EUR

SIC03 Description

Manufacture of basic pharmaceutical products

SIC07

21100

SIC07 Description

MANUFACTURE OF BASIC PHARMACEUTICAL PRODUCTS

Principal Activity

The manufacture and distribution of pharmaceutical products.

 

 

Commentary

 

Multiple CCJs recorded against the company.

The company's credit rating has dropped from 76 to 63 but the company still indicates good creditworthiness.

The credit limit on this company has fallen 10.1% in comparison to the previously suggested credit limit.

Sales in the latest trading period increased 9.2% on the previous trading period.

Net Worth increased by 12.3% during the latest trading period.

A 6% decline in Total Assets occurred during the latest trading period.

Pre-tax profits increased by 10.7% compared to the previous trading period.

The company saw a decrease in their Cash Balance of 26.2% during the latest trading period.

The audit report contains no adverse comments.

No recent changes in directorship are recorded.

The company is part of a group.

The company was established over 37 years ago.

 

 

Key Financials

 

Year to Date

Turnover

Pre Tax Profit

Shareholder Funds

Employees

31/03/2013

€67,197,686

€8,692,215

€21,052,268

339

31/03/2012

€61,509,604

€7,851,123

€20,408,126

349

31/03/2011

€60,300,646

€4,988,036

€20,653,378

329

 

 

Payment Information Summary

 

Days Beyond Terms

Trend Indicator

                         Average Payment Experience  What are Creditsafe Users saying about this company's payment behavior? This is Information on a target company's payment behaviour supplied directly by Creditsafe companies based on their direct experience of the company.

 

 

N/A

27

Company DBT

UK Average DBT

Steady

   

Improving Worsening


Within Terms 91+ Days

 

 

 

CJ

 

Total Number of Exact CJs -

2

Total Value of Exact CJs -

€8,635

Total Number of Possible CJs -

0

Total Value of Possible CJs -

€0

Total Number of Satisfied CJs -

0

Total Value of Satisfied CJs -

€0

 

Exact CJ Details

 

Date

Court

Amount

Status

Case Number

Date Paid

Plaintiff Name

10/08/2009

 

€4,461

JUDGEMENT

 

 

 

12/05/2009

Clonmel

€4,174

JUDGEMENT

38/2009

 

LA CREME RECRUITMENT

 

Possible CJ Details

 

There are no possible CJ details

 

 

Mortgage Summary

 

Outstanding

1

Satisfied

8

 

 

 

Total Current Directors

2

Total Current Secretaries

1

Total Previous Directors / Company Secretaries

11

 

 

Current Directors

 

Name

SIRJIWAN SINGH

Date of Birth

26/12/1957

Officers Title

 

Nationality

 

Present Appointments

3

Function

Director

Appointment Date

01/10/2006

 

 

Address

83 DUCHESS PLACE, OFF VICTORIA ROAD, CHESTER CH2 2JL, UK

 

 

 

 

 

Name

FERGAL MURPHY

Date of Birth

02/07/1971

Officers Title

 

Nationality

 

Present Appointments

3

Function

Director

Appointment Date

31/07/2009

 

 

Address

11 GLENDINE WOODS, BALLYFOYLE ROAD, KILKENNY

 

 

 

 

 

 

Current Company Secretary

 

Name

DAMIEN MARTIN

Date of Birth

21/07/1947

Officers Title

 

Nationality

 

Present Appointments

9

Function

Company Secretary

Appointment Date

19/04/1996

 

 

Address

AIRMOUNT COTTAGE, ARD GAOITHE, CLONMEL, CO TIPPERARY

 

 

 

 

 

 

Top 20 Shareholders

 

Name

Currency

Share Count

Share Type

Nominal Value

WOCKPHARMA IRELAND LTD

EUR

2,985,128

ORDINARY

 

WOCKPHARMA IRELAND LTD

EUR

120

ORDINARY A

 

Unable to report percentage holdings as filed Shareholder listing is not full.

 

 

Financials

 

Profit & Loss

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/12/08

Weeks

52

52

52

65

52

Currency

EUR

EUR

EUR

EUR

EUR

Consolidated A/cs

N

N

N

N

N

Turnover

€67,197,686

€61,509,604

€60,300,646

€71,367,892

€59,842,870

Export

-

-

-

-

-

Cost of Sales

€39,088,187

€38,474,515

€36,534,734

€44,795,788

€37,317,894

Gross Profit

€28,109,499

€23,035,089

€23,765,912

€26,572,104

€22,524,976

Wages & Salaries

€13,761,022

€12,846,554

€12,051,580

€15,365,268

€12,224,567

Directors Emoluments

€186,474

€163,352

€89,994

€217,397

€136,701

Operating Profit

€8,872,925

€8,094,318

€5,341,500

€1,913,936

€5,932,766

Depreciation

€1,240,974

€1,561,752

€1,578,305

€2,024,849

€1,426,818

Audit Fees

€30,000

€30,000

€30,000

€28,500

€45,000

Interest Payments

€180,710

€243,195

€353,464

€342,497

€312,673

Pre Tax Profit

€8,692,215

€7,851,123

€4,988,036

€1,571,439

€5,771,338

Taxation

-€630,561

-€853,384

-€309,268

€297,554

€29,140

Profit After Tax

€8,061,654

€6,997,739

€4,678,768

€1,868,993

€5,800,478

Dividends Payable

€6,875,619

€7,225,774

€6,142,924

€9,589,710

€6,313,268

Retained Profit

€1,186,035

-€228,035

-€1,464,156

-€7,720,717

-€512,790

 

Balance Sheet

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/12/08

Tangible Assets

€10,740,707

€11,548,151

€12,374,045

€13,319,459

€14,383,388

Intangible Assets

0

€1,667,913

€2,049,544

€2,496,048

€2,139,984

Total Fixed Assets

€10,740,707

€13,216,064

€14,423,589

€15,815,507

€16,523,372

Stock

€12,733,276

€10,452,437

€8,818,633

€10,801,245

€11,230,168

Trade Debtors

€16,577,705

€17,687,088

€17,742,048

€14,751,523

€15,087,949

Cash

€4,282,145

€5,801,646

€4,878,773

€2,500,356

€4,579,767

Other Debtors

€3,226,997

€3,443,662

€1,681,610

€652,350

€566,663

Miscellaneous Current Assets

0

0

0

€68,368

€256,390

Total Current Assets

€36,820,123

€37,384,833

€33,121,064

€28,773,842

€31,720,937

Trade Creditors

€7,625,092

€9,375,278

€5,765,149

€5,833,269

€5,429,129

Bank Loans & Overdrafts

€2,711,655

€5,672,915

€6,006,647

€5,661,311

€5,966,903

Other Short Term Finance

€6,537,422

€4,692,814

€6,851,985

€3,010,449

€2,052,845

Miscellaneous Current Liabilities

€6,093,591

€6,816,751

€7,493,872

€4,214,665

€3,946,926

Total Current Liabilities

€22,967,760

€26,557,758

€26,117,653

€18,719,694

€17,395,803

Bank Loans & Overdrafts and LTL

€6,252,457

€9,307,928

€6,780,269

€9,358,581

€6,837,337

Other Long Term Finance

€2,987,677

€2,861,391

0

0

0

Total Long Term Liabilities

€3,540,802

€3,635,013

€773,622

€3,697,270

€870,434

 

Capital & Reserves

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/12/08

Called Up Share Capital

€373,291

€373,291

€373,291

€373,291

€373,291

P & L Account Reserve

€19,597,045

€18,411,010

€18,639,045

€20,103,201

€27,823,918

Revaluation Reserve

-

-

-

-

-

Sundry Reserves

€1,081,932

€1,623,825

€1,641,042

€1,695,893

€1,780,863

Shareholder Funds

€21,052,268

€20,408,126

€20,653,378

€22,172,385

€29,978,072

Other Financial Items

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/12/08

Net Worth

€21,052,268

€18,740,213

€18,603,834

€19,676,337

€27,838,088

Working Capital

€13,852,363

€10,827,075

€7,003,411

€10,054,148

€14,325,134

Total Assets

€47,560,830

€50,600,897

€47,544,653

€44,589,349

€48,244,309

Total Liabilities

€26,508,562

€30,192,771

€26,891,275

€22,416,964

€18,266,237

Net Assets

€21,052,268

€20,408,126

€20,653,378

€22,172,385

€29,978,072

 

Cash Flow

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/12/08

Net Cashflow from Operations

-

-

-

-

-

Net Cashflow before Financing

-

-

-

-

-

Net Cashflow from Financing

-

-

-

-

-

Increase in Cash

-

-

-

-

-

 

Miscellaneous

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/12/08

Contingent Liability

NO

NO

NO

NO

NO

Capital Employed

€24,593,070

€24,043,139

€21,427,000

€25,869,655

€30,848,506

Number of Employees

339

349

329

314

325

Auditors

BDO

Auditor Comments

The audit report contains no adverse comments

Bankers

ALLIED IRISH BANKS PLC

Bank Branch Code

 

 

Ratios

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/12/08

Pre-tax profit margin %

12.94

12.76

8.27

2.20

9.64

Current ratio

1.60

1.41

1.27

1.54

1.82

Sales/Net Working Capital

4.85

5.68

8.61

7.10

4.18

Gearing %

29.70

45.60

32.80

42.20

22.80

Equity in %

44.30

41.70

45.40

52.70

65

Creditor Days

41.30

55.48

34.80

37.18

33.02

Debtor Days

89.79

104.66

107.09

94.04

91.77

Liquidity/Acid Test

1.04

1.01

0.93

0.96

1.17

Return On Capital Employed %

35.34

32.65

23.27

6.07

18.70

Return On Total Assets Employed %

18.27

15.51

10.49

3.52

11.96

Current Debt Ratio

1.09

1.30

1.26

0.84

0.58

Total Debt Ratio

1.25

1.47

1.30

1.01

0.60

Stock Turnover Ratio %

18.94

16.99

14.62

15.13

18.76

Return on Net Assets Employed %

41.28

38.47

24.15

7.08

19.25

 

 

Status History

 

No Status History found

 

 

Event History

 

Date

Description

06/11/2013

New Accounts Filed

06/11/2013

New Accounts Filed

04/11/2013

Annual Returns

26/11/2012

New Accounts Filed

24/11/2012

Annual Returns

15/11/2011

Annual Returns

15/11/2011

New Accounts Filed

18/11/2010

New Accounts Filed

17/11/2010

Annual Returns

13/11/2010

Annual Returns

13/11/2010

New Accounts Filed

13/11/2010

New Accounts Filed

08/02/2010

Annual Returns

08/02/2010

New Accounts Filed

24/12/2009

Annual Returns

 

 

Previous Company Names

 

No Previous Names found

 

 

Statistics

 

Group

12 companies

Linkages

69 companies

Countries

In 12 countries

 

 

Summary

 

Holding Company

WOCKPHARMA IRELAND LIMITED

Ownership Status

Intermediately Owned

Ultimate Holding Company

WOCKHARDT

 

 

Group structure

 

Company Name

 

Registered Number

Latest Key Financials

Consol. Accounts

Turnover

WOCKHARDT

 

N/A

31.03.2013

-

€864,611,832

WOCKHARDT BIO AG

 

N/A

-

-

 

WOCKPHARMA IRELAND L...

 

IE387540

31.03.2013

N

 

PINEWOOD LABORATOR...

 

IE056296

31.03.2013

N

€67,197,686

NONASH LIMITED

 

IE170152

31.03.2013

N

 

WOCKHARDT EU OPERATION...

 

N/A

-

-

 

WOCKHARDT UK LIMITED

 

05835570

31.03.2013

N

£82,724,000

WOCKHARDT UK HOLDINGS...

 

02825053

31.03.2013

Y

£29,581,000

C P PHARMACEUTICALS...

 

00482106

31.03.2013

N

£29,581,000

WALLIS GROUP LIMITED

 

02924314

31.03.2013

Y

 

WALLIS LABORATORY...

 

00498833

31.03.2013

N

 

WALLIS LICENSING L...

 

02924316

31.03.2013

N

 

 

Business Owner Links

 

Business Name

Business No

Business Status.

PINEWOOD LABORATORIES LIMITED

IE056296

 

PINEWOOD HEALTHCARE

117670

NORMAL

CADUSA HEALTHCARE

192288

NORMAL

DARRAGH HEALTHCARE

167868

NORMAL

 

 

Statistics

 

Group

12 companies

Linkages

69 companies

Countries

In 12 countries

 

 

Other Linked companies

 

Name

 

Number

Latest Key Financials

Turnover

CAROL INFO SERVICES

 

11-21942

31.03.2011

€3,185,538

WOCKHARDT FRANCE (HOLDINGS) SAS

 

497915900

31.12.2012

€111,000

STEG VERMÖGENSVERWALTUNGS GMBH

 

HRB 170538

31.12.2011

 

JOSSA ARZNEI GMBH

 

HRB 115822

31.12.2011

 

PHARMA RADEBEUL GMBH

 

HRB 22653

31.12.2011

 

SANTO HOLDING (DEUTSCHLAND) GMBH

 

HRB 174392

31.12.2011

€191,664,867

SIEMENS & CO. HEILWASSER UND QUELLENPRODUKTE DES STAATSBADES BAD EMS GMBH & CO KG

 

HRA 1650

31.12.2012

 

STEG EMERGING MARKETS REAL ESTATE GMBH

 

HRB 170816

31.12.2011

 

STEG EUROPA IMMOBILIEN GMBH

 

HRB 170817

31.12.2011

 

XELESANA GMBH

 

HRB 172460

31.12.2011

 

ARISTO PHARMA GMBH

 

HRB 137723 B

31.12.2011

 

PHARMA WERNIGERODE GMBH

 

HRB 101306

31.12.2011

 

ADVANCE PHARMA GMBH

 

HRB 110933 B

31.12.2011

 

AREVIPHARMA GMBH

 

HRB 23835

31.12.2011

 

AICURIS VERWALTUNGS-GMBH

 

HRB 20379

31.12.2012

 

ESPARMA GMBH

 

HRB 9439

31.12.2011

 

ARISTO PHARMA VERTRIEBS GMBH

 

HRB 134156 B

31.12.2011

 

STEG PROJEKT 102 GMBH

 

HRB 179663

31.12.2010

 

STEG PROJEKT 106 GMBH

 

HRB 179882

31.12.2011

 

STEG PROJEKT 104 GMBH

 

HRB 179883

31.12.2011

 

 

Unregistered - Exact CJ Details

 

Date

Court

Amount

Status

Case Number

Date Paid

Plaintiff Name

12/05/2009

Clonmel

€4,174

JUDGEMENT

38/2009

 

LA CREME RECRUITMENT

 

Unregistered - Possible CJ Details

 

No CJs found

 

Registered - Exact CJ Details

 

Date

Court

Amount

Status

Case Number

Date Paid

10/08/2009

 

€4,461

JUDGEMENT

 

 

 

Registered - Possible CJ Details

 

No CJs found

 

 

Mortgage Details

 

Mortgage Type:

A charge for the purpose of securing any issue of debentures. A charge on uncalled share capital of

Date Charge Created:

09/01/07

 

 

Date Charge Registered:

26/01/07

 

 

Date Charge Satisfied:

-

 

 

Status:

NOT SATISFIED

 

 

Person(s) Entitled:

ICICI BANK U.K. PLC

Amount Secured:

 

Details:

The Liabilities (as defined in Schedule 2 attached fo ofrm C1)

 

Mortgage Type:

MORTGAGE/CHARGE.

Date Charge Created:

01/03/99

 

 

Date Charge Registered:

15/03/99

 

 

Date Charge Satisfied:

11/04/07

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ALLIED IRISH BANKS PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

LETTER OF UNDERTAKING FROM SOLICITORS.

Date Charge Created:

09/11/98

 

 

Date Charge Registered:

23/11/98

 

 

Date Charge Satisfied:

11/04/07

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ALLIED IRISH BANKS PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A DEBENTURE.

Date Charge Created:

25/06/96

 

 

Date Charge Registered:

01/07/96

 

 

Date Charge Satisfied:

11/04/07

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

AIB COMMERCIAL SERVICES LIMITED

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A DEBENTURE.

Date Charge Created:

11/01/89

 

 

Date Charge Registered:

18/01/89

 

 

Date Charge Satisfied:

11/04/07

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ALLIED IRISH BANKS PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

CHATTEL MORTGAGE.

Date Charge Created:

04/07/83

 

 

Date Charge Registered:

18/07/83

 

 

Date Charge Satisfied:

11/11/03

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A MORTGAGE.

Date Charge Created:

17/06/80

 

 

Date Charge Registered:

07/07/80

 

 

Date Charge Satisfied:

11/04/07

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

ALLIED IRISH BANKS PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

Mortgage Type:

A DEBENTURE.

Date Charge Created:

10/04/80

 

 

Date Charge Registered:

30/04/80

 

 

Date Charge Satisfied:

11/11/03

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

 

Details:

ALL SUMS COLLATERALLY DUE

 

Mortgage Type:

A DEBENTURE.

Date Charge Created:

10/04/80

 

 

Date Charge Registered:

30/04/80

 

 

Date Charge Satisfied:

11/11/03

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

HUBRIS LTD

Amount Secured:

 

Details:

ALL SUMS COLLATERALLY DUE

 

Mortgage Type:

A DEED OF MORTGAGE DEBENTURE.

Date Charge Created:

28/06/78

 

 

Date Charge Registered:

28/06/78

 

 

Date Charge Satisfied:

11/11/03

 

 

Status:

FULLY SATISFIED

 

 

Person(s) Entitled:

INDUSTRIAL CREDIT CORPORATION PLC

Amount Secured:

 

Details:

ALL SUMS NOW DUE OR HEREAFTER TO BECOME DUE FROM THE COMPANY TO THE PERSON(S) ENTITLED

 

 

Creditor Details

 

 

No Creditor Data

Total Value

-

 

 

 

Trade Debtors / Bad Debt Detail

 

 

No Debtor Data

Total Value

-

 

 

 

Previous Director/Company Secretaries

 

Name

Current Directorships

Previous Directorships

ROBIN CLIFFORD

1

4

MICHAEL COSTELLO

4

2

ROBIN CLIFFORD

1

4

EDWARD TOWNSLEY

1

1

DAMIEN MARTIN

9

5

TONY HYNDS

1

2

DANIEL O'RIORDAN

1

2

SANJEEV GULATI

0

1

MANISH GUPTA

0

3

MICHAEL CARMODY

0

1

ANNE KENNEDY

11

3

Average Invoice Value

€156.24

 

Invoices available

615

 

Paid

563

 

Outstanding

52

 

 

Trade Payment Data is information that we collect from selected third party partners who send us information about their whole sales ledger.

 

 

Within Terms

0-30 Days

31-60 Days

61-90 Days

91+ Days

Paid

458

87

5

8

5

Outstanding

0

10

36

5

1

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.99

UK Pound

1

Rs.101.37

Euro

1

Rs.84.82

 

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.